Pacific Biosciences of California PACB
$ 2.62
4.39%
Quarterly report 2024-Q1
added 05-09-2024
Pacific Biosciences of California Cash and Cash Equivalents 2011-2024 | PACB
Annual Cash and Cash Equivalents Pacific Biosciences of California
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
180 M | 325 M | 461 M | 81.6 M | 29.6 M | 18.8 M | 16.5 M | 16.8 M | 33.6 M | 36.4 M | 26.4 M | 46.5 M | 58.9 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
461 M | 16.5 M | 102 M |
Quarterly Cash and Cash Equivalents Pacific Biosciences of California
2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
76.6 M | 180 M | 386 M | 209 M | 354 M | 325 M | 304 M | 310 M | 429 M | 461 M | 425 M | 460 M | 932 M | 81.6 M | 81.6 M | 81.6 M | 81.6 M | 29.6 M | 29.6 M | 29.6 M | 29.6 M | 18.8 M | 18.8 M | 18.8 M | 18.8 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 36.4 M | 36.4 M | 36.4 M | 36.4 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 58.9 M | 58.9 M | 58.9 M | 58.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
932 M | 16.5 M | 119 M |